Dr. Lorraine Nolan, Chief Executive of the Health Products Regulatory Authority (HPRA), the Irish regulatory agency, discusses the key objectives of the Strategic Plan 2016–2020, HPRA’s active participation in European and international regulatory associations, and her commitment to positioning HPRA as a driving force to support Ireland in its quest to become the global hub for innovation.
You were appointed Chief Executive in January 2016. What new mandate were you given?
"We are now facing a transition to become a global leader in innovation. The HPRA intends to play a key role in supporting that transition."
